{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Cedars-Sinai
Cedars-Sinai
  • Sign In
  • Live Courses
  • On-Demand Courses
  • Grand Rounds and RSS
  • Resources
  • CME Planning
  • COVID-19
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Use My Cedars Login
Login with my CloudCME™ account
Enter your email and password to login:



Login

New to CloudCME? Create an Account:

Create New Account
Forgot Your Password?

Login Tips: 
All Cedars-Sinai Medical Staff have an account in the system. The account is not linked to other C-S systems. If you do not know which email address is used for your account, please contact the CME Office; do NOT create a new account.

For all users: If you do not have the password for your account, click the "Forgot Your Password?" link.

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##






Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =


  • -- Select Degree --
  • BSN
  • CCC-SLP
  • CCLS
  • CRT
  • DC
  • DDS
  • DMD
  • DNAP
  • DNP
  • DO
  • DPM
  • LCSW
  • LVN
  • MBBCh
  • MBBS
  • MD
  • MD, PhD
  • MPH
  • MS
  • MSN
  • MSW
  • None
  • NP
  • OT
  • Other
  • OTR/L
  • PA
  • PharmD
  • PhD
  • PsyD
  • PT
  • RD
  • RN
  • RN, BSN
  • RPh
  • RRT
  • RT
  • RVT

Please enter your degree:





Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

4th Annual Cedars-Sinai Gastrointestinal Tumor Conference: Bringing the Future of Cancer Care to our Patients Today


4th Annual Cedars-Sinai Gastrointestinal Tumor Conference: Bringing the Future of Cancer Care to our Patients Today Banner

  • Overview
  • Register
  • Faculty
  • Schedule
  • Exhibitor Registration
Add to Calendar 4th Annual Cedars-Sinai Gastrointestinal Tumor Conference: Bringing the Future of Cancer Care to our Patients Today 3/18/2023 7:00:00 AM 3/18/2023 2:00:00 PM America/Los_Angeles For More Details: https://cedars.cloud-cme.com/gicancercme Online and Cedars-Sinai Harvey Morse Conference Center false MM/DD/YYYY


Date & Location
Saturday, March 18, 2023, 7:00 AM - 2:00 PM, Online and Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA

Target Audience
Specialties - Endocrinology & Metabolism, Family / General Medicine, Gastroenterology, Hepatology, Internal Medicine, Medical Genetics, Nuclear Medicine, Oncology, Pain Management, Palliative Care, Pathology & Laboratory Medicine, Radiation Oncology, Radiology
Professions - Physician

Overview
The fourth annual Cedars-Sinai Gastrointestinal Tumor Conference will provide concise and comprehensive updates on the most recent research and advances in therapy for gastrointestinal cancers. A stellar faculty has been assembled to share developments in precision medicine, research, and immunotherapeutic approaches to the treatment of cancers of the pancreas, liver, and gastric/esophagus. Invited faculty will present a comprehensive bench to bedside review of immune therapy for GI malignancies, detail immune therapies for pancreatic cancer, and explore advances in biomarkers and immunotherapy in gastroesophageal cancers. Biomarker strategies for neuroendocrine and rare tumors will be presented and participants will also have an opportunity to review immune-related toxicities. Join your colleagues for this important half day educational activity that will enhance your understanding of GI cancers and provide you with valuable information to inform your clinical decision-making and treatment approaches for your patients.


Objectives
  1. Consider advances in biomarkers and therapy to better inform treatment decision-making for patients with gastroesophageal cancers
  2. Use AJCC or other appropriate staging in clinical practice, including the use of appropriate prognostic indicators and evidence-based national guidelines for treatment planning
  3. Evaluate the basic science of immune therapy for GI malignancies and the implications for transfer from bench to bedside
  4. Increase knowledge of therapy for neuroendocrine tumors and biomarker identification of novel therapies
  5. Identify and implement optimal strategies for managing therapy-related side effects and toxicities in patients treated with therapeutic agents
  6. Anticipate the needs, problems, and issues of cancer survivors and develop an individualized wellness plan in partnership with cancer survivors, their families and the healthcare team

Registration

In-Person
In-person-Physicians: $49
In-person-Non-physician: Free
In-person-Resident/Fellow: Free
In-person-Industry - $99.00

Virtual
Virtual-Physicians: $99
Virtual- Non-physicians: Free
Virtual-Resident/Fellow: Free

Add optional product:
Cedars-Sinai In-person Art Tour from 1p – 2p


 

Refund Policy:
All cancellations must be submitted in writing and refunds will be subject to an administrative charge. To view the policy, click here. Please e-mail cancellation request to [email protected]. If you do not receive confirmation of your cancellation via e-mail, please call (310) 423-5548.


Disclaimer
All educational materials provided during and after the course are for your personal use only and should not be reproduced or distributed in any manner without the express permission of Cedars-Sinai.

Right to Cancel or Postpone
Cedars-Sinai reserves the right to cancel or postpone any course due to unforeseen circumstances. In the unlikely event that Cedars-Sinai must cancel or postpone this course, the registration fee will be fully refunded. Cedars-Sinai is not responsible for any related costs, charges or expenses to participants, including fees assessed by airline, travel or lodging agencies.

Health and Safety Protocols
As you know, the health and safety of our community are always our top priorities at Cedars-Sinai. Participants in any event should be thoughtful about their individual risks and consider avoiding public gatherings if they are of higher risk.

Click here to review the current in-person Cedars-Sinai CME Event Protocols.



Accreditation

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Cedars-Sinai Medical Center designates this Live Activity for a maximum of 5.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician Attendance
A certificate of participation will be provided to other health care professionals requesting credits. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.

American Board of Internal Medicine (ABIM) MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.0 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.


Credits
AMA PRA Category 1 Credit(s)™ (MD, DO) (5.00 hours), Non-Physician Attendance (RN, NP, PA and Others) (5.00 hours), ABIM MOC Part 2 (5.00 hours)


Keywords: LIVEMOC



Mitigation of Relevant Financial Relationships


Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Faculty Member Information
Role in activity
Name of Ineligible Company(s) / Nature of Relationship(s)
Jun Gong, MD
Cedars-Sinai
Course Director
Advisor-EMD Serono (Relationship has ended)|Advisor-Pfizer, Inc. (Relationship has ended)|Advisor-Elsevier|Advisor-Exelixis (Relationship has ended)|Advisor-QED Therapeutics (Relationship has ended)|Advisor-Natera (Relationship has ended)|Advisor-Bayer Corporation (Relationship has ended)|Advisor-Basilea (Relationship has ended)|Advisor-HalioDx (Relationship has ended)|Advisor-Eisai, Inc.|Advisor-Janssen (Relationship has ended)|Advisor-Aveo (Relationship has ended)
Arsen Osipov, MD
Cedars-Sinai
Course Director
Nothing to disclose
Andrew E Hendifar, MD
Cedars-Sinai
Course Director, Faculty
Consultant-Ipsen (Relationship has ended)|Consultant-Amgen|Advisor-Merck and Company, Inc.
Ghassan Abou-Alfa, MD
Memorial Sloan Kettering Center
Faculty
PrincipalNamedInvestigator-Arcus|PrincipalNamedInvestigator-AstraZeneca|PrincipalNamedInvestigator-BioNtech|PrincipalNamedInvestigator-Bristol-Myers Squibb|PrincipalNamedInvestigator-Celgene|PrincipalNamedInvestigator-Roche|PrincipalNamedInvestigator-Helsinn|PrincipalNamedInvestigator-Puma|PrincipalNamedInvestigator-QED|PrincipalNamedInvestigator-Yiviva|Consultant-AstraZeneca|Consultant-Autem|Consultant-Boehringer Ingelheim Vetmedica GmbH|Consultant-Eisai, Inc.|Consultant-Exelixis|Consultant-Roche|Consultant-Helio|Consultant-Incyte|Consultant-Ipsen|Consultant-Newbridge|Consultant-Merck and Company, Inc.|Consultant-Novartis AG|Consultant-QED|Consultant-Servier|Consultant-Yiviva
Tanios S. Bekaii-Saab, MD
Faculty
Research Funding (to institution): Agios, Arys, Arcus, Atreca, Boston Biomedical, Bayer, Eisai, Celgene, Lilly, Ipsen, Clovis, Seattle Genetics, Genentech, Novartis, Mirati, Merus, Abgenomics, Incyte, Pfizer, BMS. Consulting (to institution): Ipsen, Arcus, Pfizer, Seattle Genetics, Bayer, Genentech, Incyte, Eisai, Merus, Merck KGA and Merck. Consulting (to self): Stemline, AbbVie, Boehringer Ingelheim, Janssen, Daiichi Sankyo, Natera, TreosBio, Celularity, Caladrius Biosciences, Exact Science, Sobi, Beigene, Kanaph, Astra Zeneca, Deciphera, Zai Labs, MJH Life Sciences, Aptitude Health, Illumina and Foundation Medicine IDMC/DSMB: Fibrogen, Suzhou Kintor, Astra Zeneca, Exelixis, Merck/Eisai, PanCan and 1Globe. Scientific Advisory Board: Imugene, Immuneering, Xilis, Replimune, Artiva and Sun Biopharma. Royalties: Uptodate Inventions/Patents: WO/2018/183488: HUMAN PD1 PEPTIDE VACCINES AND USES THEREOF – Licensed to Imugene WO/2019/055687: METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER CACHEXIA – Licensed to Recursion-Relationship_has_not_ended
Robert A Figlin, MD
Cedars-Sinai
Faculty
Nothing to disclose
Pamela Kunz, MD
Faculty
Heinz-Josef Lenz, MD
Faculty
Consultant-Roche|Consultant-Bristol-Myers Squibb|Advisor-3T Bioscience|Consultant-oncocyte|Consultant-G1 Therapeutics|Consultant-Isofol|Consultant-Fulgent|Consultant-Jazz Therapeutics|Consultant-Novigenix
Mark Lewis, MD
Faculty
Speaker-AstraZeneca
Eileen O'Reilly, MD
Memorial Sloan Kettering Center
Faculty
PrincipalNamedInvestigator-Arcus|PrincipalNamedInvestigator-AstraZeneca|PrincipalNamedInvestigator-BioNtech|PrincipalNamedInvestigator-Bristol-Myers Squibb|PrincipalNamedInvestigator-Celgene|PrincipalNamedInvestigator-Roche|PrincipalNamedInvestigator-Helsinn|PrincipalNamedInvestigator-Puma|PrincipalNamedInvestigator-QED|PrincipalNamedInvestigator-Yiviva|Consultant-AstraZeneca|Consultant-Autem|Consultant-Boehringer Ingelheim Vetmedica GmbH|Consultant-Eisai, Inc.|Consultant-Exelixis|Consultant-Roche|Consultant-Helio|Consultant-Incyte|Consultant-Ipsen|Consultant-Merck and Company, Inc.|Consultant-Newbridge|Consultant-Novartis AG|Consultant-QED|Consultant-Servier|Consultant-Yiviva
Vinay Prasad, MD
Faculty
Franco Roviello, MD
University of Siena
Faculty
Nothing to disclose
Lei Zheng, MD
John Hopkins Sidney Kimmel Comprehensive Cancer Center
Faculty
PrincipalNamedInvestigator-Bristol-Myers Squibb|PrincipalNamedInvestigator-Merck and Company, Inc.|PrincipalNamedInvestigator-AstraZeneca|PrincipalNamedInvestigator-Amgen|Consultant-novarock|PrincipalNamedInvestigator-novarock (Relationship has ended)|PrincipalNamedInvestigator-Halozyme (Relationship has ended)|Consultant-ambrx (Relationship has ended)|Advisor-Pfizer, Inc. (Relationship has ended)|Advisor-Xilio|Advisor-QED (Relationship has ended)|Advisor-alphamab|Advisor-Biosion|Advisor-Amberstone|Consultant-Snow Lake Capital (Relationship has ended)|Consultant-Tavotek (Relationship has ended)|Consultant-Clinical trial options, LLC|Consultant-Novagenesis
Loretta Y. So, PhD
Cedars-Sinai
Nurse Planner
Nothing to disclose
Justin Byun

Other Planning Committee Member
Nothing to disclose
Meghan Laszlo
Other Planning Committee Member
Nothing to disclose
Tomas M Wagmister, MSW
Cedar Sinai
Other Planning Committee Member
Nothing to disclose

Saturday, March 18, 2023

Registration, Breakfast & Exhibits
7:30AM - 7:55AM
Introduction
7:55AM - 8:00AM
Andrew E Hendifar, MD
Cedars Sinai Cancer: A Health System Approach to Cancer Care
8:00AM - 8:10AM
Robert A Figlin, MD
Molecular Twin Initiative to advance precision cancer treatment
8:10AM - 8:30AM
Molecular Landscape in CRC: Shaping the Future
8:30AM - 9:00AM
Heinz-Josef Lenz, MD
The Challenges of Treating Pancreatic Cancer.
9:00AM - 9:30AM
Eileen O'Reilly, MD
Cholangiocarcinoma and HCC
9:30AM - 10:00AM
Ghassan Abou-Alfa, MD
Using social media to improve cancer care.
10:00AM - 10:30AM
Mark Lewis, MD
Overcoming obstacles to optimize care in Neuroendocrine tumors
10:30AM - 11:00AM
Pamela Kunz, MD
TBD
11:00AM - 11:30AM
Franco Roviello, MD
Role of Neoadjuvant Treatment in Pancreatic Cancer
11:30AM - 12:00PM
Lei Zheng, MD
Targeted Therapies in GI Cancer - Immunotherapy
12:00PM - 12:30PM
Tanios S. Bekaii-Saab, MD
Lessons from the cancer community from the COVID pandemic.
12:30PM - 1:00PM
Vinay Prasad, MD
Optional: Cedars-Sinai In-Person Art Tour
1:00PM - 2:00PM

To view the Exhibit Prospectus, Click here for the -  Fourth Annual Cedars-Sinai Gastrointestinal Tumor Conference

Contact Us:
CME Office
Cedars-Sinai
8700 West Beverly Blvd., CME
Los Angeles, CA 90048
Phone: 3104235548
Email: [email protected]
Website: https://cedars.cloud-cme.com/gicancercme

Exhibit at this Event

Exhibitor Packages

Exhibitor Package - Gold Level Price: $2500.00
Includes:
  • Recognition as a Gold Level Supporter Exhibitor
  • Number of Exhibitor Badges: 2
  • Exhibit Location: Assigned Table Space

Deadline for order commitment is 3/15/2023 12:00:00 AM.

Exhibitor Package - Silver Level Price: $1500.00
Includes:
  • Recognition as a Silver Level Supporter Exhibitor
  • Number of Exhibitor Badges: 0
  • Exhibit Location: Posting on Meeting Sponsor Page

Deadline for order commitment is 3/15/2023 12:00:00 AM.

Disclosure of Financial Relationships Form CME Agent Forms CME Application

 

 Privacy  |  Accreditation  | Cedars-Sinai CME Homepage 

Follow Us

Facebook 

Join Our Email List| Phone: 310-423-5548 | Email: [email protected]

© 2022 Cedars-Sinai. All Rights Reserved. A 501(c)(3) non-profit organization